Keeping in mind all the pitfalls that Bear pointed out I find the data in Table 3 encouraging. Trials that have Biomarkers, Cardiovascular, 85.7% POS(Probability Of Success). Diabetic, recent ACS, Low HDL, High CRP. Let's hope the trial design works as well as most others with biomarkers.
tada